NYSE:BSXBoston Scientific Stock Price, Forecast & News

Boston Scientific's stock was trading at $33.86 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BSX stock has increased by 18.4% and is now trading at $40.10.
View which stocks have been most impacted by Coronavirus.

24 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Boston Scientific in the last year. There are currently 2 hold ratings, 19 buy ratings and 3 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Boston Scientific.

Boston Scientific is scheduled to release its next quarterly earnings announcement on Wednesday, October 28th 2020.
View our earnings forecast for Boston Scientific.

Boston Scientific Co. (NYSE:BSX) issued its earnings results on Wednesday, July, 29th. The medical equipment provider reported $0.08 earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.12. The medical equipment provider had revenue of $2 billion for the quarter, compared to the consensus estimate of $1.68 billion. Boston Scientific had a net margin of 39.18% and a return on equity of 12.86%. The firm's revenue for the quarter was down 23.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.39 EPS.
View Boston Scientific's earnings history.

24 equities research analysts have issued 12-month price targets for Boston Scientific's shares. Their forecasts range from $25.00 to $58.00. On average, they expect Boston Scientific's share price to reach $45.00 in the next twelve months. This suggests a possible upside of 12.2% from the stock's current price.
View analysts' price targets for Boston Scientific.

News coverage about BSX stock has trended negative recently, InfoTrie reports. The research firm identifies positive and negative media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Boston Scientific earned a coverage optimism score of -2.2 on InfoTrie's scale. They also gave media headlines about the medical equipment provider a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the near term.
View the latest news about Boston Scientific.

Boston Scientific saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 12,000,000 shares, an increase of 21.7% from the March 31st total of 9,860,000 shares. Based on an average daily trading volume, of 12,000,000 shares, the days-to-cover ratio is presently 1.0 days.
View Boston Scientific's Short Interest.

Some companies that are related to Boston Scientific include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Becton Dickinson and (BDX), Stryker (SYK), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Teleflex (TFX), Hologic (HOLX), Varian Medical Systems (VAR), Steris (STE) and ABIOMED (ABMD).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Boston Scientific investors own include NVIDIA (NVDA), Alibaba Group (BABA), salesforce.com (CRM), Bank of America (BAC), Walt Disney (DIS), Cisco Systems (CSCO), AT&T (T), Paypal (PYPL), Intel (INTC) and Micron Technology (MU).

Boston Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "BSX."

Boston Scientific's stock is owned by a number of institutional and retail investors. Top institutional investors include Viking Global Investors LP (1.32%), Newport Trust Co (0.63%), Swiss National Bank (0.41%), Sumitomo Mitsui Trust Holdings Inc. (0.40%), New York State Common Retirement Fund (0.22%) and Bessemer Group Inc. (0.22%). Company insiders that own Boston Scientific stock include Arthur C Butcher, Daniel J Brennan, David A Pierce, Desiree Ralls-Morrison, Edward F Mackey, Eric Francis Yves Thepaut, Halliday Hamish, Jeffrey B Mirviss, Jodi Euerle Eddy, John Bradley Sorenson, John E Sununu, Joseph Michael Fitzgerald, Kevin J Ballinger, Maulik Nanavaty, Michael F Mahoney, Wendy Carruthers, Williamson Scott, Xin Warren Wang and Yoshiaki Fujimori.
View institutional ownership trends for Boston Scientific.

BSX stock was sold by a variety of institutional investors in the last quarter, including Viking Global Investors LP, Toronto Dominion Bank, Sumitomo Mitsui Trust Holdings Inc., Strs Ohio, Atalanta Sosnoff Capital LLC, Diamond Hill Capital Management Inc., California Public Employees Retirement System, and Sector Gamma AS. Company insiders that have sold Boston Scientific company stock in the last year include Arthur C Butcher, Daniel J Brennan, David A Pierce, Desiree Ralls-Morrison, Eric Francis Yves Thepaut, Jeffrey B Mirviss, John Bradley Sorenson, Joseph Michael Fitzgerald, Maulik Nanavaty, and Wendy Carruthers.
View insider buying and selling activity for Boston Scientific.

BSX stock was purchased by a variety of institutional investors in the last quarter, including Locust Wood Capital Advisers LLC, SeaTown Holdings Pte. Ltd., Fisher Asset Management LLC, Kornitzer Capital Management Inc. KS, Partners Capital Investment Group LLP, Bessemer Group Inc., Hardman Johnston Global Advisors LLC, and Teacher Retirement System of Texas. Company insiders that have bought Boston Scientific stock in the last two years include John E Sununu, and Williamson Scott.
View insider buying and selling activity for Boston Scientific.

Shares of BSX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of BSX stock can currently be purchased for approximately $40.10.

Boston Scientific has a market capitalization of $57.37 billion and generates $10.74 billion in revenue each year. The medical equipment provider earns $4.70 billion in net income (profit) each year or $1.58 on an earnings per share basis. Boston Scientific employs 36,000 workers across the globe.

The official website for Boston Scientific is www.bostonscientific.com.

Boston Scientific's mailing address is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. The medical equipment provider can be reached via phone at 508-683-4000 or via email at [email protected]